LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1

被引:17
|
作者
Ji, Weidan [1 ,2 ]
Peng, Zhangxiao [1 ,2 ]
Sun, Bin [1 ,2 ]
Chen, Lei [1 ,2 ]
Zhang, Qin [1 ,2 ]
Guo, Minggao [3 ]
Su, Changqing [1 ,2 ]
机构
[1] Navy Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Mol Oncol, Shanghai, Peoples R China
[2] Navy Mil Med Univ, Natl Ctr Liver Canc, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Gen Surg, Sch Med, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
LpCat1; STAT1; cell cycle; proliferation; metastasis; hepatocellular carcinoma (HCC); LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 1; UP-REGULATION; PROGRESSION; EXPRESSION; PROLIFERATION; OVEREXPRESSION; INDUCTION; ARREST; GROWTH; PHASE;
D O I
10.3389/fonc.2021.678714
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is a malignant cancer with rapid proliferation and high metastasis ability. To explore the crucial genes that maintain the aggressive behaviors of cancer cells is very important for clinical gene therapy of HCC. LpCat1 was reported to be highly expressed and exert pro-tumorigenic effect in a variety of cancers, including HCC. However, its detailed molecular mechanism remained unclear. In this study, we confirmed that LpCat1 was up-regulated in HCC tissues and cancer cell lines. The overexpressed LpCat1 promoted the proliferation, migration and invasion of HCC cells, and accelerated cell cycle progression, while knocking down LpCat1 significantly inhibited cell proliferation, migration and invasion in vitro and in vivo, and arrested HCC cells at G0/G1 phase. Moreover, we proved for the first time that LpCat1 directly interacted with STAT1 which was generally recognized as a tumor suppressor in HCC. High levels of LpCat1 in HCC could inhibit STAT1 expression, up-regulate CyclinD1, CyclinE, CDK4 and MMP-9, and decrease p27kip1 to promote cancer progression. Conversely, down-regulation of LpCat1 would cause the opposite changes to repress the viability and motility of HCC cells. Consequently, we concluded that LpCat1 was a contributor to progression and metastasis of HCC by interacting with STAT1.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
    Rong-Quan He
    Jian-Di Li
    Xiu-Fang Du
    Yi-Wu Dang
    Lin-Jie Yang
    Zhi-Guang Huang
    Li-Min Liu
    Liu-Feng Liao
    Hong Yang
    Gang Chen
    [J]. Cancer Cell International, 21
  • [2] LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
    He, Rong-Quan
    Li, Jian-Di
    Du, Xiu-Fang
    Dang, Yi-Wu
    Yang, Lin-Jie
    Huang, Zhi-Guang
    Liu, Li-Min
    Liao, Liu-Feng
    Yang, Hong
    Chen, Gang
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [3] LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
    Zhang, Hongbin
    Xu, Ke
    Xiang, Qin
    Zhao, Lijuan
    Tan, Benxu
    Ju, Ping
    Lan, Xiufu
    Liu, Yi
    Zhang, Jian
    Fu, Zheng
    Li, Chao
    Wang, Jinzhi
    Song, Jixiang
    Xiao, Yun
    Cheng, Zhaobo
    Wang, Yan
    Zhang, Shu
    Xiang, Tingxiu
    [J]. GENES & DISEASES, 2022, 9 (01) : 151 - 164
  • [4] LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
    Lan Li
    Xiao Wang
    Yanni Ding
    Nini Hui
    Bingjie Su
    Min Yang
    [J]. European Journal of Medical Research, 27
  • [5] LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
    Li, Lan
    Wang, Xiao
    Ding, Yanni
    Hui, Nini
    Su, Bingjie
    Yang, Min
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [6] LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
    Mingyue Tao
    Jing Luo
    Tong Gu
    Xiaojuan Yu
    Zhen Song
    Yali Jun
    Hao Gu
    Kairong Han
    Xiujuan Huang
    Weiyong Yu
    Su’an Sun
    Zhengwei Zhang
    Lu Liu
    Xiaofei Chen
    Li Zhang
    Chao Luo
    Qilong Wang
    [J]. Cell Death & Disease, 12
  • [7] LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
    Tao, Mingyue
    Luo, Jing
    Gu, Tong
    Yu, Xiaojuan
    Song, Zhen
    Jun, Yali
    Gu, Hao
    Han, Kairong
    Huang, Xiujuan
    Yu, Weiyong
    Sun, Su'an
    Zhang, Zhengwei
    Liu, Lu
    Chen, Xiaofei
    Zhang, Li
    Luo, Chao
    Wang, Qilong
    [J]. CELL DEATH & DISEASE, 2021, 12 (09)
  • [8] Inhibition of SIRT7 promotes STAT1 activation and STAT1-dependent signaling in hepatocellular carcinoma
    Dong, Ling
    Wei, Xufu
    Yu, Le
    Li, Yixin
    Chen, Lixue
    [J]. CELLULAR SIGNALLING, 2024, 114
  • [9] Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
    Lin, Tong
    Zhang, E.
    Lin, Zhimei
    Peng, Lisheng
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 9117 - 9130
  • [10] LPCAT1 promotes melanoma cell proliferation via Akt signaling
    Wang, Yuqian
    Huang, Yingjian
    Wang, Yan
    Zhang, Wen
    Wang, Ning
    Bai, Ruimin
    Luo, Ruiting
    Tuo, Huihui
    Zheng, Yan
    [J]. ONCOLOGY REPORTS, 2024, 51 (05)